Press Releases

BOULDER, Colo., Jan. 8, 2020 /PRNewswire/ -- ArcherDX, Inc., a molecular diagnostics company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine, today announced that Jason Myers, Ph.D., Chief Executive Officer, will present an overview of the company and its products at the 38

SAN FRANCISCO, Jan. 8, 2020 /PRNewswire/ -- RARE in the Square Union Square, San FranciscoJanuary 13-15, 20208:00 a.m. – 5:00 p.m., daily

HONG KONG and SUZHOU and HANGZHOU, China, Jan. 8, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D, and manufacturing of antibody-based therapeutics, announces today that it has sealed a

BIRMINGHAM, Ala. and SAN ANGELO, Texas, Jan. 8, 2020 /PRNewswire/ -- Birmingham, Ala.-based Encompass Health Corp. (NYSE: EHC) and San Angelo, Texas-based Shannon Health today announced plans to form a joint venture for a new, 40-bed, freestanding inpatient rehabilitation h

CHARLOTTE, N.C., Jan. 8, 2020 /PRNewswire/ -- cbdMD, Inc. a nationally recognized consumer cannabidiol (CBD) brand (NYSE American: YCBD), and the Registrar at National Day Calendar, have declared January as "National CBD Month."As the popularity of CBD continues to rise, millions of Americans are educating themselves on the prospective properties of CBD and how it

NORTH CHICAGO, Ill., Jan. 8, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the creation of a new global business, Allergan Aesthetics, an AbbVie company, and the proposed leadership team for the combined company, effective upon the expected first-quarter 2020 close of the Allergan acquisition.  Al

SAN CARLOS, Calif., Jan. 8, 2020 /PRNewswire/ -- Natera, Inc. (

DURHAM, N.C., Jan. 8, 2020 /PRNewswire/ -- Alcami Corporation, a leading provider of fully-integrated custom end-to-end solutions for the pharmaceutical and biopharmaceutical industries, today announced the sale of its preclinical and early stage active pharmaceutical ingredient (API) facility in Weert, Netherlands to Mercache

VANCOUVER, Jan. 8, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical needs, today announced that Eric A. Adams, President & CEO will be presenting at the Biotech Sh

SAN FRANCISCO, Jan. 8, 2020 /PRNewswire/ -- Today BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) and